Sleep medicine billing
Most coverage policy describes services. Sleep medicine's describes measurements. The national determinations set out which category of device may produce a diagnosis and whether it had to be attended in a laboratory, define an apnea as a cessation of airflow for at least ten seconds, define a hypopnea by duration, reduction and desaturation, and then set the events-per-hour thresholds a test has to clear -- with a rule for what happens when the study was shorter than two hours.
- Type I polysomnography is covered only when performed attended in a sleep laboratory
- A Type IV device must measure three or more channels, one of which is airflow
- The apnea-hypopnea and respiratory disturbance thresholds are set in the determination
- CPAP coverage is initially limited to twelve weeks, and continues only for those who benefit
This is an educational guide to how billing works for sleep medicine — its workflow, coding, and payer considerations. It is general information, not a statement that US Medical Billing serves this specialty, and not billing, coding, or legal advice.
What makes sleep medicine billing distinct
The determination on sleep testing does something unusual: it makes the category of equipment, and where it was used, part of the coverage question. Type I attended facility-based polysomnography is covered to aid the diagnosis of obstructive sleep apnea in beneficiaries with clinical signs and symptoms of it, if performed attended in a sleep laboratory facility. Type II or Type III devices are covered if performed unattended in or out of a sleep laboratory, or attended in one. Type IV devices are covered only where they measure three or more channels, one of which is airflow, on the same attended-or-unattended terms. Devices measuring three or more channels including actigraphy, oximetry and peripheral arterial tone are covered on those terms too.
The determination is explicit about the consequence: other diagnostic sleep tests for the diagnosis of obstructive sleep apnea, other than those it names for prescribing CPAP, are not sufficient for the coverage of CPAP and are not covered. A study can be clinically informative, competently performed and still be the wrong instrument for the coverage question. It also matters that the same test can change status by setting -- Type I is defined by attendance in a laboratory in which a technologist supervises the recording during sleep time and has the ability to intervene if needed.
The therapy determination then defines the finding itself. Apnea is defined as a cessation of airflow for at least ten seconds. Hypopnea is defined as an abnormal respiratory event lasting at least ten seconds with at least a thirty percent reduction in thoracoabdominal movement or airflow compared to baseline, and with at least a four percent oxygen desaturation. These are not clinical conventions the payer happens to accept; they are the terms in which coverage is written.
Coverage of an initial twelve weeks of CPAP follows if either threshold is met: an apnea-hypopnea index or respiratory disturbance index of at least fifteen events per hour; or an index of at least five and no more than fourteen events per hour together with documented symptoms of excessive daytime sleepiness, impaired cognition, mood disorders or insomnia, or documented hypertension, ischemic heart disease, or history of stroke. The index is calculated on the average number of events per hour -- and the determination closes the obvious gap: where it is calculated on less than two hours of continuous recorded sleep, the total number of recorded events must be at least the number that would have been required across a full two-hour period. A short study cannot reach a threshold by dividing by a small denominator.
Then the therapy is only provisionally covered. Coverage of CPAP is initially limited to a twelve-week period, to identify beneficiaries who benefit from it, and is subsequently covered only for those diagnosed with obstructive sleep apnea who benefited during that period. The provider must also educate the beneficiary in proper use of the device before use, with a consistently available, willing and able caregiver in the home able to compensate. So the revenue cycle carries a diagnostic gate, an equipment gate, an education obligation and a trial period whose outcome has to be documented before ongoing therapy is payable.
How sleep medicine billing flows
Every stage is gated by a specification -- of the device, of the setting, of the event, or of the benefit demonstrated.
Establishing signs and symptoms first
The testing determination covers these studies to aid diagnosis in beneficiaries who have clinical signs and symptoms indicative of obstructive sleep apnea. The clinical evaluation is a precondition of the test, not a formality after it.
Common operational challenges
The difficulties come from coverage conditions that attach to equipment, to a room, and to a period of time.
A test that was right clinically and wrong for coverage
A study performed on a device outside the named categories, or a Type I performed unattended, produces a usable clinical result and an unusable basis for therapy coverage. Nothing about the report signals the problem.
A threshold that depends on evidence from elsewhere
The lower band requires documented symptoms or documented cardiovascular history. Those live in the referring record, not the sleep study, and have to be assembled before the claim rather than after a denial.
A trial period nobody is watching
Twelve weeks of provisional coverage ends whether or not anyone has recorded whether the patient benefited. The evidence has to be created during the window, and the window closes quietly.
Two claims, two rulebooks
The diagnostic study and the device that follows it are billed through different channels with different requirements. A practice that owns only one side still depends on the other side being right.
Documentation and coding considerations
The notes below describe coverage conditions and documentation requirements from the national coverage determinations; they do not reproduce any code descriptions.
What each device category is
Type I is comprehensive attended facility-based polysomnography including at least electroencephalography, electro-oculography, electromyography, heart rate or electrocardiography, airflow, breathing or respiratory effort and arterial oxygen saturation, in a laboratory where a technologist supervises the recording during sleep time and can intervene. Type II monitors have a minimum of seven channels; Type III a minimum of four including ventilation or airflow, heart rate or electrocardiography, and oxygen saturation; Type IV devices may measure one, two, three or more parameters without meeting all the criteria of a higher category.
Which are covered, and where
Type I only if performed attended in a sleep laboratory. Type II or Type III if performed unattended in or out of a laboratory, or attended in one. Type IV only where measuring three or more channels, one of which is airflow, on the same terms. Devices measuring three or more channels including actigraphy, oximetry and peripheral arterial tone, on those terms as well.
The definitions the score is built from
Apnea is a cessation of airflow for at least ten seconds. Hypopnea is an abnormal respiratory event lasting at least ten seconds with at least a thirty percent reduction in thoracoabdominal movement or airflow compared to baseline, and at least a four percent oxygen desaturation.
The two-hour rule
The index is calculated on the average number of events per hour. Where it is calculated on less than two hours of continuous recorded sleep, the total number of recorded events must be at a minimum the number of events that would have been required in a two-hour period.
What the therapy determination requires around the device
A positive diagnosis requires a clinical evaluation together with a positive study of a covered type; the test must have been previously ordered by the treating physician and furnished under appropriate physician supervision; and the provider of CPAP must educate the beneficiary in proper use before use, with a consistently available and able caregiver in the home able to compensate.
Denial and rejection risks
Most of these are settled at the point the study is scheduled, on facts the claim never states.
An instrument outside the covered categories
The determination states that other diagnostic sleep tests for diagnosing obstructive sleep apnea are not sufficient for CPAP coverage and are not covered. That is a category judgement, not a documentation shortfall.
A Type I study that was not attended in a laboratory
Attendance in a sleep laboratory facility is part of what makes Type I polysomnography covered. The same recording performed elsewhere is not the covered test.
A Type IV device short of three channels or missing airflow
Coverage for Type IV devices is conditioned on measuring three or more channels, one of which is airflow. A device configuration decision made for convenience can remove the study from coverage entirely.
A borderline index with no supporting documentation
Between five and fourteen events per hour, coverage depends on documented symptoms or documented hypertension, ischemic heart disease or history of stroke. Without them the index alone does not reach the threshold.
A short study scored as though it were a full one
Where the index rests on less than two hours of continuous recorded sleep, the event count must meet the two-hour equivalent. A rate derived from a small denominator is exactly what the determination forecloses.
Payer-process considerations
Coverage here was deliberately moved from contractor discretion to national policy, and it still has a research pathway attached.
National policy replaced local discretion
The determination records that coverage of the sleep tests themselves was previously left to local contractor discretion, and that from March 2009 the named test types are nationally covered. Older local guidance is not a reliable guide to the current position.
A coverage-with-evidence-development route exists
For adult beneficiaries who do not qualify on the stated criteria, the therapy determination provides limited coverage for CPAP furnished to enrolled subjects in a clinical study addressing specified research questions and meeting a list of study standards.
The device side has its own supplier requirements
CPAP is furnished as durable medical equipment, so the study, the prescription and the device travel through different claim channels with different documentation expectations, and a gap in one surfaces as a denial in another.
Commercial plans and Medicare Advantage vary
The determinations described here are Original Medicare's. Commercial payers and Medicare Advantage plans set their own testing criteria, often prefer home testing by policy, and commonly require prior authorization and adherence data on their own terms.
Revenue-cycle checkpoints
The first three are decided when the study is booked, and cannot be repaired afterwards.
- Record the clinical signs and symptoms that make the study a covered diagnostic aid before it is scheduled
- Match the device category, and the channels it will actually record, to the determination's list
- Confirm the setting -- attended in a laboratory where the determination requires it, unattended where that is permitted
- Evidence that the treating physician ordered the test and that it was furnished under appropriate physician supervision
- Score against the determination's definitions of apnea and hypopnea, and apply the two-hour minimum event count where recording was short
- Assemble the documented symptoms or cardiovascular history the lower threshold band depends on
- Record the beneficiary education before device use, and who in the home can operate it
- Capture evidence of benefit during the twelve-week trial, not after it has closed
Related & connected
Services, tools, background reading and definitions that connect to the sleep medicine revenue-cycle steps above.
Related services
Calculators & tools
- Place of service code lookupWhere the study happened, which here is part of whether it is covered.
- Medicare claim readiness checklistThe order, supervision and documentation checks a study claim depends on.
- Prior authorization request checklistAssembling clinical evidence for the plans that require approval before testing or therapy.
From the Knowledge Base
- National and local coverage determinationsThe instruments that define these findings, and the shift here from local discretion to national policy.
- Place of service on professional claimsReporting the setting on a claim where attended-versus-unattended carries coverage weight.
- Medical necessity denialWhat to do when necessity is defined by a number and the study did not reach it.
- Gathering documentation for authorizationAssembling the symptom and comorbidity evidence a borderline index depends on.
Glossary
- National coverage determinationThe instrument that defines an apnea, a hypopnea and the thresholds between them.
- Place of serviceThe claim element that says whether a study was performed in a laboratory.
- Medical necessityHere made unusually concrete: a defined event, counted per hour, against a stated threshold.
- Covered serviceThe category a study falls outside of when the device was not one the determination names.
Frequently asked questions
Which sleep tests can Medicare use to diagnose obstructive sleep apnea?
The determination on sleep testing names four situations. Type I polysomnography is covered when used to aid the diagnosis in beneficiaries with clinical signs and symptoms indicative of obstructive sleep apnea, if performed attended in a sleep laboratory facility. Type II or Type III devices are covered if performed unattended in or out of a sleep laboratory, or attended in one. Type IV devices are covered where they measure three or more channels, one of which is airflow, on those same terms. Devices measuring three or more channels that include actigraphy, oximetry and peripheral arterial tone are also covered on those terms. Other diagnostic sleep tests for diagnosing obstructive sleep apnea are stated to be not sufficient for coverage of CPAP and not covered.
Does it matter whether the study was attended?
For Type I, decisively. It is covered when performed attended in a sleep laboratory facility, which the determination describes as a laboratory in which a technologist supervises the recording during sleep time and has the ability to intervene if needed. Types II and III, and Type IV devices meeting the channel requirement, may be performed unattended in or out of a sleep laboratory, or attended in one. So attendance is not a quality preference in this policy -- for one category of study it is part of the coverage condition, and the same recording made outside that setting is a different thing for payment purposes.
What makes a sleep study positive enough for CPAP to be covered?
An apnea-hypopnea index or respiratory disturbance index of at least fifteen events per hour; or an index of at least five and no more than fourteen events per hour together with documented symptoms of excessive daytime sleepiness, impaired cognition, mood disorders or insomnia, or documented hypertension, ischemic heart disease or history of stroke. The determination defines the events being counted: apnea as a cessation of airflow for at least ten seconds, and hypopnea as an abnormal respiratory event lasting at least ten seconds with at least a thirty percent reduction in thoracoabdominal movement or airflow compared to baseline and at least a four percent oxygen desaturation. A positive diagnosis also requires a clinical evaluation alongside the positive study.
What happens if the patient did not sleep for long?
The determination anticipates it. The index is calculated on the average number of events per hour, and where it is calculated based on less than two hours of continuous recorded sleep, the total number of recorded events must be at a minimum the number of events that would have been required in a two-hour period. In other words a short recording does not get to reach the threshold by dividing a handful of events by a small denominator -- the absolute event count has to stand up as if the study had run the full two hours.
Is CPAP covered indefinitely once it is prescribed?
No. Coverage of CPAP is initially limited to a twelve-week period, expressly to identify beneficiaries diagnosed with obstructive sleep apnea who benefit from it, and CPAP is subsequently covered only for those who benefited during that period. The provider of the device must also conduct education of the beneficiary before use to ensure they have been educated in its proper operation, and the determination notes a caregiver -- a family member, for example -- may be compensatory if consistently available in the home and willing and able to operate the device safely. Practically, that makes the trial window a documentation exercise as much as a clinical one.
Sources
Last reviewed August 1, 2026.
- Centers for Medicare & Medicaid Services (CMS)National Coverage Determination 240.4.1, Sleep Testing for Obstructive Sleep Apnea (OSA) -- the descriptions of Type I attended facility-based polysomnography and of Type II, III and IV portable monitors and their channel minimums; the four nationally covered situations including the attended-in-a-laboratory condition for Type I and the three-or-more-channels-including-airflow condition for Type IV; the coverage of devices measuring three or more channels including actigraphy, oximetry and peripheral arterial tone; the statement that other diagnostic sleep tests are not sufficient for CPAP coverage and are not covered; and the record that coverage of the tests themselves was previously left to local contractor discretion
- Centers for Medicare & Medicaid Services (CMS)National Coverage Determination 240.4, Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) -- the initial twelve-week limitation and the requirement that continued coverage depends on benefit during that period; the beneficiary education obligation and the compensatory caregiver; the requirement of a clinical evaluation together with a positive study of a named type; the requirement that the test be previously ordered by the treating physician and furnished under appropriate physician supervision; the apnea-hypopnea and respiratory disturbance index thresholds and the second limb requiring documented symptoms or conditions; the definitions of apnea and hypopnea; the minimum event count where recording was under two hours; and the coverage-with-evidence-development pathway
Ready to improve your revenue cycle?
Tell us about your practice and we’ll tell you where we would start.